{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T16:12:01Z","timestamp":1788883921843,"version":"build-2803163510"},"reference-count":13,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2005,5,1]],"date-time":"2005-05-01T00:00:00Z","timestamp":1114905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2005,5]]},"DOI":"10.4065\/80.5.671","type":"journal-article","created":{"date-parts":[[2009,1,24]],"date-time":"2009-01-24T01:26:10Z","timestamp":1232760370000},"page":"671-673","source":"Crossref","is-referenced-by-count":61,"title":["Cocaine-Induced Pseudovasculitis"],"prefix":"10.4065","volume":"80","author":[{"given":"Daphne R.","family":"Friedman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan D.","family":"Wolfsthal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.4065\/80.5.671_bib1","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s11926-002-0028-7","article-title":"Pseudovasculitis: mechanisms of vascular injury and clinical spectrum","volume":"4","author":"Grau","year":"2002","journal-title":"Curr Rheumatol Rep"},{"key":"10.4065\/80.5.671_bib2","first-page":"1711","article-title":"Mimickers of vasculitis","volume":"Vol 2","author":"Sack","year":"2001"},{"key":"10.4065\/80.5.671_bib3","first-page":"348","article-title":"Schoenlein-Henoch purpura with necrotizing vasculitis after cocaine snorting [letter]","volume":"43","author":"Chevalier","year":"1995","journal-title":"Clin Nephrol"},{"issue":"2, pt 2","key":"10.4065\/80.5.671_bib4","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/S0190-9622(87)70062-0","article-title":"Thrombotic phenomena associated with intravenous cocaine","volume":"16","author":"Heng","year":"1987","journal-title":"J Am Acad Dermatol"},{"key":"10.4065\/80.5.671_bib5","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1159\/000018500","article-title":"Cocaine-related Stevens-Johnson syndrome","volume":"201","author":"Hofbauer","year":"2000","journal-title":"Dermatology"},{"key":"10.4065\/80.5.671_bib6","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1046\/j.1365-2133.1999.03087.x","article-title":"Urticarial vasculitis following cocaine use [letter]","volume":"141","author":"Hofbauer","year":"1999","journal-title":"Br J Dermatol"},{"key":"10.4065\/80.5.671_bib7","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1183\/09031936.96.09010175","article-title":"Cocaine-induced Churg-Strauss vasculitis","volume":"9","author":"Orriols","year":"1996","journal-title":"Eur Respir J"},{"key":"10.4065\/80.5.671_bib8","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S0190-9622(85)80101-8","article-title":"Cocaine-related bullous disease [letter]","volume":"12","author":"Tomecki","year":"1985","journal-title":"J Am Acad Dermatol"},{"key":"10.4065\/80.5.671_bib9","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/00005792-200111000-00005","article-title":"Cocaine-induced midline destructive lesions: clinical, radiographic, histopathologic, and serologic features and their differentiation from Wegener granulomatosis","volume":"80","author":"Trimarchi","year":"2001","journal-title":"Medicine (Baltimore)"},{"key":"10.4065\/80.5.671_bib10","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1093\/qjmed\/94.11.615","article-title":"The diagnostic value of anti-neutrophil cytoplasmic antibody testing in a routine clinical setting","volume":"94","author":"McLaren","year":"2001","journal-title":"QJM"},{"key":"10.4065\/80.5.671_bib11","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1006\/clim.2001.5200","article-title":"Detection of anti-neutrophil cytoplasmic antibodies under actual clinical testing conditions","volume":"103","author":"Russell","year":"2002","journal-title":"Clin Immunol"},{"key":"10.4065\/80.5.671_bib12","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/00002281-200401000-00004","article-title":"Clinical applications of antineutrophil cytoplasmic antibody testing","volume":"16","author":"Schmitt","year":"2004","journal-title":"Curr Opin Rheumatol"},{"key":"10.4065\/80.5.671_bib13","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0190-9622(94)70224-1","article-title":"Cutaneous Wegener's granulomatosis: clinical, histopathologic, and immunopathologic features of thirty patients","volume":"31","author":"Daoud","year":"1994","journal-title":"J Am Acad Dermatol"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619611631005?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619611631005?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,22]],"date-time":"2018-12-22T08:22:17Z","timestamp":1545466937000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619611631005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,5]]},"references-count":13,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2005,5]]}},"alternative-id":["S0025619611631005"],"URL":"https:\/\/doi.org\/10.4065\/80.5.671","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2005,5]]}}}